Breaking News, Trials & Filings

Trials & Filings in Brief: Jan. 14, 2014

BioMarin, D-Pharm, GSK, MediciNova, MEI, Nektar

By: Gil Roth

President, Pharma & Biopharma Outsourcing Association

Preclinical MediciNova posts positive results in mouse NASH test . . . read more Phase I Nektar doses first patients in neuropathic pain trial . . . read more Phase II BioMarin begins dosing in dwarfism trial . . . read more D-Pharm recruits first pancreatitis subject . . . read more MEI doses first patient in MDS trial . . . read more Filings GSK wins Breakthrough status for Tafinlar . . . read more...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters